IKBKE promotes glioblastoma progression by establishing the regulatory feedback loop of IKBKE/YAP1/miR-Let-7b/i (Q38698126)

5 September 2017

title

IKBKE promotes glioblastoma progression by establishing the regulatory feedback loop of IKBKE/YAP1/miR-Let-7b/i (English)

1 reference

5 September 2017

1 reference

Zhimeng Zhang

1

1 reference

5 September 2017

Jie Lu

2

1 reference

5 September 2017

Gaochao Guo

3

1 reference

5 September 2017

Yi Yang

4

1 reference

5 September 2017

Shicai Dong

5

1 reference

5 September 2017

Yang Liu

6

1 reference

5 September 2017

Yang Nan

7

1 reference

5 September 2017

Yue Zhong

8

1 reference

5 September 2017

Kai Yu

9

1 reference

5 September 2017

Qiang Huang

10

1 reference

5 September 2017

publication date

1 July 2017

1 reference

5 September 2017

1 reference

5 September 2017

volume

39

1 reference

5 September 2017

issue

7

1 reference

5 September 2017

page(s)

1010428317705575

1 reference

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

5 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1010428317705575

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317705575

A single NFκB system for both canonical and non-canonical signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317705575

Integrative genomic approaches identify IKBKE as a breast cancer oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317705575

IKBKE is over‐expressed in glioma and contributes to resistance of glioma cells to apoptosis via activating NF‐κB

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317705575

Deregulation of IKBKE is associated with tumor progression, poor prognosis, and cisplatin resistance in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317705575

IKBKE is induced by STAT3 and tobacco carcinogen and determines chemosensitivity in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317705575

IKBKE Upregulation is Positively Associated with Squamous Cell Carcinoma of the Lung In Vivo and Malignant Transformation of Human Bronchial Epithelial Cells In Vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317705575

Kinome expression profiling identifies IKBKE as a predictor of overall survival in clear cell renal cell carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317705575

The Hippo pathway: regulators and regulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317705575

The dual functions of YAP-1 to promote and inhibit cell growth in human malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317705575

The emerging roles of YAP and TAZ in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317705575

YAP is a candidate oncogene for esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317705575

Clinical significance of yes-associated protein overexpression in cervical carcinoma: the differential effects based on histotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317705575

Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317705575

Yes-Associated Protein 1 Is Widely Expressed in Human Brain Tumors and Promotes Glioblastoma Growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317705575

let-7 microRNAs in development, stem cells and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317705575

Overexpressed let-7a inhibits glioma cell malignancy by directly targeting K-ras, independently of PTEN

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317705575

MicroRNAs let-7b/i suppress human glioma cell invasion and migration by targeting IKBKE directly

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317705575

Let-7 microRNA inhibits the proliferation of human glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317705575

Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317705575

Emerging roles of TEAD transcription factors and its coactivators in cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317705575

Advances in targeting IKK and IKK-related kinases for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317705575

Phosphorylation of the tumor suppressor CYLD by the breast cancer oncogene IKKepsilon promotes cell transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317705575

IκB kinase ε phosphorylates TRAF2 to promote mammary epithelial cell transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317705575

IKBKE Protein Activates Akt Independent of Phosphatidylinositol 3-Kinase/PDK1/mTORC2 and the Pleckstrin Homology Domain to Sustain Malignant Transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317705575

IkappaB kinase epsilon and TANK-binding kinase 1 activate AKT by direct phosphorylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317705575

The Hippo pathway and human cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317705575

YAP and TAZ: a nexus for Hippo signaling and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317705575

The let-7 family of microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317705575

Mechanisms of Lin28-mediated miRNA and mRNA regulation--a structural and functional perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317705575

How does Lin28 let-7 control development and disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317705575

The Hippo pathway effectors TAZ/YAP regulate dicer expression and microRNA biogenesis through Let-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317705575

RAS is regulated by the let-7 microRNA family

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317705575

Let-7 repression leads to HMGA2 overexpression in uterine leiomyosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317705575

Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317705575

MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317705575

Lethal-7 is down-regulated by the hepatitis B virus x protein and targets signal transducer and activator of transcription 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317705575

21 January 2018

Identifiers

DOI

10.1177/1010428317705575

1 reference

5 September 2017

1 reference